Verve Therapeutics competitorsClear all

ImmusanT's top competitors include Oxford BioTherapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
ImmusanT
ImmusanT
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
Oxford BioTherapeutics
Oxford BioTherapeutics
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Founding Date
Founding Date
2010
Founding Date
2004
Type
Type
Private
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
Milton, GB HQ
San Jose, US
Employees
Employees
2
Employees
313% increase

Funding

Total funding raised
Total funding raised
$ 72.8m
Total funding raised
$ 21.6m
For sources of this data, please see the company profile

View company profiles

Oxford BioTherapeutics
HQ
Milton, GB
Employees
31↑ 3% increase

Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

View company